Jeffrey Young named Chief Financial Officer; Ganesh Mugundu, M.Pharm, Ph.D., appointed Vice President, Head of Clinical Development; and Richard ...
A series of new bioinformatics and biotechnology developments unveiled on April 29 span antimicrobial resistance surveillance, AI-driven drug target discovery, synthetic genome engineering, and ...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork ...
That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...
April 20, 2026) - Huxley Health Inc. ("Huxley" or the "Company"), together with its Aerasyn Biotech division, a biotechnology platform advancing next-generation therapeutics through AI-guided ...
Immunic Inc. IMUX on Tuesday announced it appointed Michael Panzara as its Chief Medical Officer, effective April 24, 2026, as the company looks to advance its clinical and regulatory strategy. The ...
The National Academy of Sciences announced today the election of 120 members and 25 international members in recognition of ...
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative ...
TCR-based therapies redirect T cells to diseased cells and can fine-tune immune responses. The approach overcomes limitations ...
The Signaling Collagen Shot, designed to support skin health--without animal sources, and formulated for taste, ritual, and real-world adherence AJDOVŠČINA, Slovenia, April 21, 2026 /PRNewswire/ -- In ...
Clinical Trial Media (CTM), a leading full-service patient recruitment and retention partner to pharmaceutical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results